STX
56
-3
KSS
51
2
ZBH
54
3
FITB
58
-2
CMI
58
8
MCD
38
2
HSY
38
-2
SIG
55
5
HOG
38
3
NWL
31
2
DFS
62
-3
ROP
65
-3
AFL
53
-2
HP
52
2
SJM
36
-2
TGNA
54
6
AIV
62
-3
MA
58
3
HSIC
44
-3
DLTR
51
-3
STX
56
-3
KSS
51
2
ZBH
54
3
FITB
58
-2
CMI
58
8
MCD
38
2
HSY
38
-2
SIG
55
5
HOG
38
3
NWL
31
2
DFS
62
-3
ROP
65
-3
AFL
53
-2
HP
52
2
SJM
36
-2
TGNA
54
6
AIV
62
-3
MA
58
3
HSIC
44
-3
DLTR
51
-3
Financhill
Back

Autolus Therapeutics PLC Quote, Financials, Valuation and Earnings

The #1 free indicator I've used for 30 years

The indicator is free... and the 23-page book I wrote for you is also free.
Sell
24

AUTL
Autolus Therapeutics PLC

Last Price:
3.48
Seasonality Move:
-14.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy a stock when it crosses this line on the chart

Here's the line to follow.

Autolus Therapeutics PLC Price Quote

$3.48
-0.01 (2.96%)
(Updated: July 4, 2024 at 5:39 AM ET)

Autolus Therapeutics PLC Key Stats

Sell
24
Autolus Therapeutics PLC (AUTL) is a Sell
Day range:
$3.38 - $3.51
52-week range:
$2.01 - $7.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.6%
Volume:
641.8K
Avg. volume:
1.3M
1-year change:
37.4%
Market cap:
$928.5M
Revenue:
$1.7M
EPS:
$-1.21

How Much Does Autolus Therapeutics PLC Make?

Data Unavailable

Is Autolus Therapeutics PLC Growing As A Company?

Autolus Therapeutics PLC Stock Price Performance

What Is Autolus Therapeutics PLC 52-Week High & Low?

Autolus Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Autolus Therapeutics PLC?

Is Autolus Therapeutics PLC Cash Flow Positive?

  • What Is AUTL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$143.7M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $561.2M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$7.9M

Autolus Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    AUTL return on invested capital is -80.74%
  • What Is Autolus Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -42.65%
  • What Is AUTL Return On Equity?
    ROE is a measure of profitability and is -80.74%

Autolus Therapeutics PLC Earnings Date & Stock Price

Autolus Therapeutics PLC Competitors

Autolus Therapeutics PLC Dividend Yield

Data Unavailable

Autolus Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -76.47%
Revenue: 681.04% -59.71%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 10.54
Upside from Last Price: 202.13%

Major Shareholders

  • How many AUTL shares are owned by institutional investors?
    192.9M AUTL shares are owned by institutional investors
  • How many AUTL shares are owned by insiders?
    0 AUTL shares are owned by insiders